×
About 353 results

ALLMedicine™ Pediatric Multiple Sclerosis Center

Research & Reviews  123 results

Obesity and Pediatric Multiple Sclerosis
https://clinicaltrials.gov/ct2/show/NCT04593082

Aug 5th, 2021 - Obesity is one possible contributor to severity of multiple sclerosis and progression of the disease. We already know that obesity is a risk determinant for acquiring MS, yet the impact of obesity on pediatric MS disease expression and course is u...

Prevalence of pediatric multiple sclerosis in Germany: A nationwide population-based an...
https://doi.org/10.1111/ene.15015
European Journal of Neurology; Frahm N, Peters M et. al.

Jul 10th, 2021 - Prevalence data are needed to reveal trends regarding the pediatric multiple sclerosis (MS) situation worldwide. The aim was to identify changes in MS diagnosis prevalence in pediatric patients over a 10-year period in Germany. This analysis is ba...

Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275506
Paediatric Drugs; Fernandez-Carbonell C, Charvet LE et. al.

May 18th, 2021 - Pediatric-onset multiple sclerosis (POMS), representing approximately 5% of all MS cases, affects the central nervous system during its ongoing development. POMS is most commonly diagnosed during adolescence but can occur in younger children as we...

Mobile Attentional Bias Modification Training in Pediatric MS
https://clinicaltrials.gov/ct2/show/NCT04441229

May 3rd, 2021 - This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long baseline evaluation, followed by at-home ABMT ap...

see more →

Clinicaltrials.gov  3 results

Obesity and Pediatric Multiple Sclerosis
https://clinicaltrials.gov/ct2/show/NCT04593082

Aug 5th, 2021 - Obesity is one possible contributor to severity of multiple sclerosis and progression of the disease. We already know that obesity is a risk determinant for acquiring MS, yet the impact of obesity on pediatric MS disease expression and course is u...

Mobile Attentional Bias Modification Training in Pediatric MS
https://clinicaltrials.gov/ct2/show/NCT04441229

May 3rd, 2021 - This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long baseline evaluation, followed by at-home ABMT ap...

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
https://clinicaltrials.gov/ct2/show/NCT01396343

Oct 18th, 2018 - The overall goal of this project is to determine whether well-established environmental and genetic risk factors for adult onset MS play an important role in susceptibility to pediatric-onset MS. Our study design is based on the hypothesis that ge...

see more →

News  13 results

Sun Exposure Linked to Reduced Pediatric MS Risk
https://www.medscape.com/viewarticle/946992

Mar 5th, 2021 - Children who have higher levels of sun exposure appear to have a substantially lower risk of developing pediatric multiple sclerosis (MS) than children who are less exposed to the sun, new research shows. The use of sunscreen does not appear to af...

Pediatric MS often goes untreated in the year after diagnosis
https://www.mdedge.com/neurology/article/202447/multiple-sclerosis/pediatric-ms-often-goes-untreated-year-after-diagnosis?channel=251
Jake Remaly

Jun 6th, 2019 - SEATTLE – About 65% of patients with pediatric multiple sclerosis (MS) do not receive disease-modifying therapy (DMT) within 1 year of diagnosis, according to an analysis of insurance claims data. Females may be more likely than males to receive D.

5 New Neurology Studies' Practice-Changing Implications
https://www.staging.medscape.com/viewarticle/907688

Jan 29th, 2019 - Dear colleagues, I am Christoph Diener, a neurologist from the University Essen in Germany. Today I'd like to discuss five noteworthy studies in the field of neurology, published this past fall. More Proof of Aspirin's Ineffectiveness The results ...

5 New Neurology Studies' Practice-Changing Implications
https://www.medscape.com/viewarticle/907688

Jan 29th, 2019 - Dear colleagues, I am Christoph Diener, a neurologist from the University Essen in Germany. Today I'd like to discuss five noteworthy studies in the field of neurology, published this past fall. More Proof of Aspirin's Ineffectiveness The results ...

PARADIGMS: Fingolimod Effective, Well Tolerated in Children
https://www.staging.medscape.com/viewarticle/901996

Sep 14th, 2018 - Children and adolescents with multiple sclerosis (MS) who are treated with fingolimod have a much lower relapse rate than those receiving interferon β-1a, although they may experience more seizures or other adverse events, phase 3 results of the P...

see more →

Patient Education  2 results see all →